Intravenous L-Citrulline

DRUG2 trials

Sponsors

Vanderbilt University, Asklepion Pharmaceuticals, LLC

Conditions

Atrial Septal DefectAtrioventricular Septal DefectBronchopulmonary DysplasiaVentricular Septal Defect

Phase 1

Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants

WithdrawnNCT00742534

Vanderbilt UniversityBronchopulmonary Dysplasia

Start: 2008-08-31End: 2009-08-31Updated: 2011-12-30

Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol

CompletedNCT01120964

Asklepion Pharmaceuticals, LLCAtrial Septal Defect, Atrioventricular Septal Defect, Ventricular Septal Defect

Start: 2010-09-30End: 2012-04-30Updated: 2022-07-27